# Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction

Study · id `cardio:ct-nct02224534` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02224534](<https://clinicaltrials.gov/study/NCT02224534>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02224534

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 326 participants.

## Technical summary

Registry record NCT02224534. Randomized; no masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 326 participants (planned count; ClinicalTrials.gov record NCT02224534, source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)
- Start date: 2014-10 (registry gives no type) (ClinicalTrials.gov record NCT02224534, source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)
- Primary completion: 2017-06 (anticipated) (ClinicalTrials.gov record NCT02224534, source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02224534, source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)
- Countries: China; Singapore; South Korea (ClinicalTrials.gov record NCT02224534, source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02224534-2016-11-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
- Acronym: HEALING-AMI
- Condition: ST Elevation Myocardial Infarction
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Lead sponsor: Gyeongsang National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Pusan National University Yangsan Hospital
- Collaborator class: OTHER
- Collaborator: National University Heart Centre, Singapore
- Collaborator class: OTHER
- Collaborator: Ulsan University Hospital
- Collaborator class: OTHER
- Collaborator: Kyungpook National University Hospital
- Collaborator class: OTHER
- Collaborator: Samsung Changwon Hospital
- Collaborator class: OTHER
- Collaborator: Kyunghee University Medical Center
- Collaborator class: OTHER
- Collaborator: Chungbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI) (`cardio:pubmed-33032710`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry organizations

## Provenance

Content hash: 441d8c82120dd7e19c0d94f21e209901ad7b6f19985c1ebc60b6866f29dc5110
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
